Published in Masui on October 01, 2011
Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J (2006) 1.41
The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J Clin Invest (2013) 1.39
Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol (2006) 1.35
Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis (2006) 1.31
Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice. Biochem Biophys Res Commun (2006) 1.14
Genetic and epigenetic alteration among three homoeologous genes of a class E MADS box gene in hexaploid wheat. Plant Cell (2007) 1.13
Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. Metabolism (2008) 1.09
Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol (2007) 1.09
Predictors of left main or three-vessel disease in patients who have acute coronary syndromes with non-ST-segment elevation. Am J Cardiol (2005) 1.07
Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care (2011) 1.02
Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension. Hypertens Res (2008) 0.99
Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus. Endocr J (2006) 0.97
Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia. Endocr J (2007) 0.91
Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens (2011) 0.91
Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction. J Cardiol (2004) 0.86
Efficacy and safety of modified Yale insulin infusion protocol in Japanese diabetic patients after open-heart surgery. Diabetes Res Clin Pract (2008) 0.83
Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients. Endocr J (2004) 0.82
Hypothermia and thiopentone sodium: individual and combined neuroprotective effects on cortical cultures exposed to prolonged hypoxic episodes. J Neurosci Res (2002) 0.82
Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6). Diabetes Res Clin Pract (2008) 0.82
Strict glycemic control ameliorates the increase of carotid IMT in patients with type 2 diabetes. Endocr J (2006) 0.81
Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2009) 0.81
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term study. Endocr J (2006) 0.80
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressure. Endocr J (2007) 0.80
N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients. Diabetes Res Clin Pract (2005) 0.80
Aldose reductase inhibitor, epalrestat, reduces lipid hydroperoxides in type 2 diabetes. Endocr J (2008) 0.79
[Reliability of a less-invasive cardiac output monitor in the perioperative period of a patient with severe dilated cardiomyopathy]. Masui (2011) 0.79
[Anesthetic management for video-assisted extended thymectomy of patients with myasthenia gravis]. Masui (2005) 0.78
Current status of emergency care for ST-elevation myocardial infarction in an urban setting in Japan. Circ J (2009) 0.78
[Anesthetic management for nephrectomy using a monopolar electrocautery in a patient implanted with a biventricular pacemaker]. Masui (2009) 0.77
Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease. Atherosclerosis (2012) 0.77
Clinical characteristics influencing the effectiveness of metformin on Japanese type 2 diabetes receiving sulfonylureas. Endocr J (2007) 0.77
Histopathologic features of fat embolism in fulminant fat embolism syndrome. Anesthesiology (2007) 0.77
Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-. Circ J (2011) 0.77
Pseudoaneurysm of the mitral-aortic intervalvular fibrosa on a native aortic valve following infective endocarditis. J Anesth (2010) 0.77
Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2010) 0.76
Relation between white blood cell counts and myocardial reperfusion in patients with recanalized anterior acute myocardial infarction. Circ J (2004) 0.76
[Perioperative management of patients with drug-eluting coronary stents presenting for non-cardiac surgery]. Masui (2008) 0.75
[Anesthesia for partial pulmonary resection in a postpneumonectomy patient]. Masui (2002) 0.75
[7-year survey of anesthesia for cesarean section--comparison of tetracaine and bupivacaine as intrathecal anesthetic agents]. Masui (2007) 0.75
Glucose homeostasis in a diabetic patient during liver transplantation: a case report. Endocr J (2007) 0.75
[Unexpected vomiting during anesthetic induction in a patient with a history of anterosternal esophageal reconstruction]. Masui (2010) 0.75
[The Influence of Preoperative Oral Carbohydrate Administration on Perioperative Blood Sugar Levels and Patients' Satisfaction]. Masui (2016) 0.75
[Thoracoscopic surgery for spontaneous pneumothorax and its anesthetic considerations]. Masui (2004) 0.75
[Preoperative evaluation, anesthetic management and postoperative complications of athetotic type cerebral palsy patients undergoing laminoplasty]. Masui (2004) 0.75
Lack of evident atherosclerosis despite multiple risk factors in glycogen storage disease type 1a with hyperadiponectinemia. Metabolism (2007) 0.75
[Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol]. Masui (2008) 0.75
[Anesthetic management for patients with compromised left ventricular function due to coronary artery disease in non-cardiac surgery]. Masui (2007) 0.75
Analysis of thermoreflectance signals and characterization of thermal conductivity of metal thin films. Rev Sci Instrum (2009) 0.75
Continuous epidural, not intravenous, droperidol inhibits pruritus, nausea, and vomiting during epidural morphine analgesia. J Clin Anesth (2002) 0.75
[Evaluation of cardiac load by measuring brain natriuretic peptide after thoracic esophagectomy and gastric tube in place]. Masui (2002) 0.75
[Postoperative nausea, vomiting and pain after pediatric outpatient surgery : comparison of laparoscopic and conventional inguinal hernia repair]. Masui (2009) 0.75
Clinical implications of intermediate QRS prolongation in the absence of bundle-branch block in patients with ST-segment-elevation acute myocardial infarction. Circ J (2005) 0.75
[Hypertrophic cardiomyopathy]. Masui (2010) 0.75